List of Excipients in API famotidine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing famotidine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Padagis US LLC | FAMOTIDINE | famotidine | 0574-0147 | CARBOXYMETHYLCELLULOSE SODIUM | |
| Padagis US LLC | FAMOTIDINE | famotidine | 0574-0147 | CELLULOSE, MICROCRYSTALLINE | |
| Padagis US LLC | FAMOTIDINE | famotidine | 0574-0147 | CITRIC ACID MONOHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing famotidine
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 | CELLULOSE, MICROCRYSTALLINE |
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 | FD&C RED NO. 40 |
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 | FD&C YELLOW NO. 6 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for famotidine
Excipient focus: ACACIA
famotidine drug variants containing ACACIA
famotidine drug variants not containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALUMINUM OXIDE
famotidine drug variants containing ALUMINUM OXIDE
famotidine drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
famotidine drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | famotidine | 16714-244 |
| Novel Laboratories Inc | famotidine | 40032-500 |
| Lupin PharmaceuticalsInc | famotidine | 43386-500 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
famotidine drug variants containing ANHYDROUS LACTOSE
famotidine drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: ASPARTAME
famotidine drug variants containing ASPARTAME
famotidine drug variants not containing ASPARTAME
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: ASPARTIC ACID
famotidine drug variants containing ASPARTIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | famotidine | 0338-5197 |
| Hikma Pharmaceuticals USA Inc | famotidine | 0641-6021 |
| HF Acquisition Co LLC DBA HealthFirst | famotidine | 51662-1375 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing ASPARTIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: BANANA
famotidine drug variants containing BANANA
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | famotidine | 31722-063 |
| Akorn | famotidine | 50383-913 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing BANANA
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZYL ALCOHOL
famotidine drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | famotidine | 0641-6021 |
| Fresenius Kabi USA LLC | famotidine | 63323-738 |
| Zydus Pharmaceuticals USA Inc | famotidine | 70710-1783 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
famotidine drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | famotidine | 0574-0147 |
| Upsher-Smith Laboratories LLC | famotidine | 0832-6045 |
| Northstar Rx LLC | famotidine | 16714-244 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
famotidine drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7141 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| Teva Pharmaceuticals USA Inc | famotidine | 0172-5728 |
| Bausch Health US LLC | famotidine | 0187-4420 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE ACETATE
famotidine drug variants containing CELLULOSE ACETATE
famotidine drug variants not containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
famotidine drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | famotidine | 0338-5197 |
| Hikma Pharmaceuticals USA Inc | famotidine | 0641-6021 |
| TARGET CORPORATION | famotidine | 11673-697 |
| >Company | >Ingredient | >NDC |
Excipient focus: CHERRY
famotidine drug variants containing CHERRY
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | famotidine | 31722-063 |
| Akorn | famotidine | 50383-913 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing CHERRY
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
famotidine drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | famotidine | 0574-0147 |
| Ajanta Pharma USA Inc | famotidine | 27241-249 |
| Camber Pharmaceuticals Inc | famotidine | 31722-063 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
famotidine drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Select Brand | famotidine | 15127-370 |
| Shopko Stores Operating Co LLC | famotidine | 37012-036 |
| Fred's Inc | famotidine | 55315-035 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: CORN SYRUP
famotidine drug variants containing CORN SYRUP
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | famotidine, calcium carbonate, and magnesium hydroxide | 16837-246 |
| Select Corporation | famotidine, calcium carbonate, and magnesium hydroxide | 52904-948 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing CORN SYRUP
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
famotidine drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7194 |
| Walgreen Company | famotidine | 0363-0701 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-7141 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
famotidine drug variants containing CROSPOVIDONE
famotidine drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 7
famotidine drug variants containing D&C RED NO. 7
famotidine drug variants not containing D&C RED NO. 7
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
famotidine drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| CVS Pharmacy | famotidine, calcium carbonate, magnesium hydroxide | 69842-802 |
| Cardinal Health 110 LLC dba Leader | famotidine, calcium carbonate, magnesium hydroxide | 70000-0316 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTRATES
famotidine drug variants containing DEXTRATES
famotidine drug variants not containing DEXTRATES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTROSE
famotidine drug variants containing DEXTROSE
famotidine drug variants not containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
famotidine drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Walgreen Company | famotidine | 0363-1203 |
| Target Corporation | famotidine | 11673-414 |
| Rite Aid Corporation | famotidine | 11822-1014 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
famotidine drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
famotidine drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
famotidine drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | famotidine | 0615-4594 |
| NCS HealthCare of KY LLC dba Vangard Labs | famotidine | 0615-8301 |
| PD-Rx Pharmaceuticals Inc | famotidine | 43063-533 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
famotidine drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Northwind Pharmaceuticals | famotidine | 51655-102 |
| NuCare PharmaceuticalsInc | famotidine | 68071-3497 |
| REMEDYREPACK INC | famotidine | 70518-1415 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 3
famotidine drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| R J General Corporation | famotidine, calcium carbonate, and magnesium hydroxide | 70264-034 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
famotidine drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine, calcium carbonate and magnesium hydroxide | 0113-0032 |
| L Perrigo Company | famotidine, calcium carbonate and magnesium hydroxide | 0113-6023 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7141 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 5
famotidine drug variants containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | famotidine, calcium carbonate, and magnesium hydroxide | 16837-246 |
| Select Corporation | famotidine, calcium carbonate, and magnesium hydroxide | 52904-948 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing FD&C YELLOW NO. 5
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 5 ALUMINUM LAKE
famotidine drug variants containing FD&C YELLOW NO. 5 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Chattem Inc | famotidine | 41167-0364 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing FD&C YELLOW NO. 5 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
famotidine drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| NCS HealthCare of KY Inc dba Vangard Labs | famotidine | 0615-4594 |
| NCS HealthCare of KY LLC dba Vangard Labs | famotidine | 0615-8301 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7141 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
famotidine drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-7141 |
| Teva Pharmaceuticals USA Inc | famotidine | 0172-5728 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7194 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
famotidine drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-7141 |
| Teva Pharmaceuticals USA Inc | famotidine | 0172-5728 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7194 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
famotidine drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Graviti Pharmaceuticals Private Limited | famotidine | 69844-097 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: FUMARIC ACID
famotidine drug variants containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | famotidine | 0832-6045 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing FUMARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
famotidine drug variants containing GLYCERYL MONOSTEARATE
famotidine drug variants not containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
famotidine drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | famotidine | 0187-4420 |
| WALGREEN CO | famotidine | 0363-1899 |
| WALGREEN CO | famotidine | 0363-4400 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
famotidine drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | famotidine | 16590-281 |
| Aidarex Pharmaceuticals LLC | famotidine | 33261-562 |
| WOCKHARDT LIMITED | famotidine | 55648-374 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
famotidine drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-7141 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7194 |
| Teva Pharmaceuticals USA Inc | famotidine | 0172-5728 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
famotidine drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| WALGREEN CO | famotidine | 0363-1899 |
| WALGREEN CO | famotidine | 0363-4400 |
| WALGREEN CO | famotidine | 0363-5300 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
famotidine drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0172-5728 |
| NCS HealthCare of KY LLC dba Vangard Labs | famotidine | 0615-4582 |
| NCS HealthCare of KY Inc dba Vangard Labs | famotidine | 0615-4594 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: INDIGOTINDISULFONATE SODIUM
famotidine drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY LLC dba Vangard Labs | famotidine | 0615-8301 |
| PD-Rx Pharmaceuticals Inc | famotidine | 43063-533 |
| Legacy Pharmaceutical Packaging LLC | famotidine | 68645-141 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOMALT
famotidine drug variants containing ISOMALT
famotidine drug variants not containing ISOMALT
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
famotidine drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7194 |
| Teva Pharmaceuticals USA Inc | famotidine | 0172-5728 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-7141 |
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
famotidine drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | famotidine | 46708-293 |
| Unit Dose Services | famotidine | 50436-1000 |
| RPK Pharmaceuticals Inc | famotidine | 53002-1199 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
famotidine drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | famotidine | 0338-5197 |
| Padagis US LLC | famotidine | 0574-0147 |
| Hikma Pharmaceuticals USA Inc | famotidine | 0641-6021 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
famotidine drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Walgreen Company | famotidine | 0363-1203 |
| Target Corporation | famotidine | 11673-414 |
| Rite Aid Corporation | famotidine | 11822-1014 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
famotidine drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | famotidine | 0641-6021 |
| HF Acquisition Co LLC DBA HealthFirst | famotidine | 51662-1375 |
| Fresenius Kabi USA LLC | famotidine | 63323-738 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
famotidine drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals Inc | famotidine, calcium carbonate, magnesium hydroxide | 0597-0315 |
| Boehringer Ingelheim Pharmaceuticals Inc | famotidine, calcium carbonate, magnesium hydroxide | 0597-0320 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL SALICYLATE
famotidine drug variants containing METHYL SALICYLATE
| Company | Ingredient | NDC |
|---|---|---|
| JC World Bell Wholesale Co Inc | famotidine, calcium carbonate, magnesium hydroxide | 50269-016 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing METHYL SALICYLATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
famotidine drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | famotidine | 50383-913 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN SODIUM
famotidine drug variants containing METHYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | famotidine | 0574-0147 |
| Upsher-Smith Laboratories LLC | famotidine | 0832-6045 |
| Northstar Rx LLC | famotidine | 16714-244 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing METHYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
famotidine drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | famotidine | 31722-017 |
| A-S Medication Solutions | famotidine | 50090-6790 |
| A-S Medication Solutions | famotidine | 50090-7178 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
famotidine drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| TARGET CORPORATION | famotidine | 11673-697 |
| MARKSANS PHARMA LIMITED | famotidine 10 mg | 25000-086 |
| Camber Pharmaceuticals Inc | famotidine | 31722-017 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
famotidine drug variants containing MINERAL OIL
famotidine drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: PEPPERMINT
famotidine drug variants containing PEPPERMINT
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | famotidine | 31722-063 |
| Akorn | famotidine | 50383-913 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing PEPPERMINT
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
famotidine drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-7141 |
| Bausch Health US LLC | famotidine | 0187-4420 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7194 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
famotidine drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0172-5728 |
| Bausch Health US LLC | famotidine | 0187-4420 |
| Baxter Healthcare Corporation | famotidine | 0338-5197 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3000
famotidine drug variants containing POLYETHYLENE GLYCOL 3000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0172-5728 |
| Apotheca Inc | famotidine | 12634-967 |
| PD-Rx Pharmaceuticals Inc | famotidine | 43063-086 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing POLYETHYLENE GLYCOL 3000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
famotidine drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | famotidine | 46708-293 |
| Unit Dose Services | famotidine | 50436-1000 |
| RPK Pharmaceuticals Inc | famotidine | 53002-1199 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
famotidine drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | famotidine | 0904-7193 |
| Contract Pharmacal Corp | famotidine | 10267-5689 |
| Select Brand | famotidine | 15127-370 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
famotidine drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0172-5728 |
| Apotheca Inc | famotidine | 12634-967 |
| SAFEWAY | famotidine | 21130-191 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
famotidine drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| ST MARY'S MEDICAL PARK PHARMACY | famotidine | 60760-736 |
| Coupler LLC | famotidine | 67046-1427 |
| NuCare PharmaceuticalsInc | famotidine | 68071-2842 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
famotidine drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | famotidine | 0615-4594 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
famotidine drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc | famotidine | 16837-889 |
| L Perrigo Company | famotidine, calcium carbonate and magnesium hydroxide | 0113-0032 |
| L Perrigo Company | famotidine, calcium carbonate and magnesium hydroxide | 0113-6023 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
famotidine drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7194 |
| Walgreen Company | famotidine | 0363-0701 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-7141 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
famotidine drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Ascent Pharmaceuticals Inc | famotidine | 43602-501 |
| Ascent Pharmaceuticals Inc | famotidine | 43602-511 |
| XLCare Pharmaceuticals Inc | famotidine | 72865-214 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONES
famotidine drug variants containing POVIDONES
famotidine drug variants not containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: POWDERED CELLULOSE
famotidine drug variants containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | famotidine | 27241-249 |
| Camber Pharmaceuticals Inc | famotidine | 31722-063 |
| Micro Labs Limited | famotidine | 42571-433 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing POWDERED CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
famotidine drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | famotidine | 50383-913 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN SODIUM
famotidine drug variants containing PROPYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | famotidine | 0574-0147 |
| Upsher-Smith Laboratories LLC | famotidine | 0832-6045 |
| Ajanta Pharma USA Inc | famotidine | 27241-249 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing PROPYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
famotidine drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7194 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-7141 |
| Bausch Health US LLC | famotidine | 0187-4420 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
famotidine drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | famotidine | 0574-0147 |
| Upsher-Smith Laboratories LLC | famotidine | 0832-6045 |
| Northstar Rx LLC | famotidine | 16714-244 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
famotidine drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | famotidine | 0338-5197 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
famotidine drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | famotidine | 0338-5197 |
| Akorn | famotidine | 50383-913 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
famotidine drug variants containing SODIUM METABISULFITE
famotidine drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
famotidine drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Contract Pharmacal Corp | famotidine | 10267-5689 |
| SAFEWAY | famotidine | 21130-191 |
| A-S Medication Solutions | famotidine | 50090-6582 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
famotidine drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| WALGREEN CO | famotidine | 0363-1899 |
| WALGREEN CO | famotidine | 0363-4400 |
| WALGREEN CO | famotidine | 0363-5300 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
famotidine drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| Teva Pharmaceuticals USA Inc | famotidine | 0172-5728 |
| NCS HealthCare of KY LLC dba Vangard Labs | famotidine | 0615-4582 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7141 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
famotidine drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| Teva Pharmaceuticals USA Inc | famotidine | 0172-5728 |
| Bausch Health US LLC | famotidine | 0187-4420 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7141 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, POTATO
famotidine drug variants containing STARCH, POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | famotidine | 62135-807 |
| CELLTRION USA INC | famotidine | 72606-509 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing STARCH, POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, PREGELATINIZED CORN
famotidine drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Select Brand | famotidine | 15127-370 |
| Shopko Stores Operating Co LLC | famotidine | 37012-036 |
| Fred's Inc | famotidine | 55315-035 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
famotidine drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Walgreen Company | famotidine | 0363-1203 |
| Target Corporation | famotidine | 11673-414 |
| Rite Aid Corporation | famotidine | 11822-1014 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
famotidine drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | famotidine | 0574-0147 |
| Upsher-Smith Laboratories LLC | famotidine | 0832-6045 |
| Northstar Rx LLC | famotidine | 16714-244 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
famotidine drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | famotidine | 0338-5197 |
| Walgreen Company | famotidine | 0363-1203 |
| Padagis US LLC | famotidine | 0574-0147 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
famotidine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | famotidine | 0338-5197 |
| Padagis US LLC | famotidine | 0574-0147 |
| Hikma Pharmaceuticals USA Inc | famotidine | 0641-6021 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
famotidine drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-7141 |
| Teva Pharmaceuticals USA Inc | famotidine | 0172-5728 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0194 |
| L Perrigo Company | famotidine | 0113-7194 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
famotidine drug variants containing TRIETHYL CITRATE
famotidine drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
famotidine drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | famotidine | 0338-5197 |
| Hikma Pharmaceuticals USA Inc | famotidine | 0641-6021 |
| Fresenius Kabi USA LLC | famotidine | 63323-738 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
famotidine drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | famotidine | 0574-0147 |
| Upsher-Smith Laboratories LLC | famotidine | 0832-6045 |
| Northstar Rx LLC | famotidine | 16714-244 |
| >Company | >Ingredient | >NDC |
famotidine drug variants not containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | famotidine | 0093-2748 |
| L Perrigo Company | famotidine | 0113-0141 |
| L Perrigo Company | famotidine | 0113-0194 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
